FTC and FDA Send Second Set of Cease-and-Desist Letters to Companies Selling Products Containing Delta-8 THC in Packaging Designed to Look Like Children’s Snacks
NEW White Paper on Prominence and Risks Related to New, High THC Potency Cannabis Products
Holiday Shopping Guide: How To Identify Misinformation in the Cannabis Marketplace
ICYMI: FDA Shares Insights & Predictions from 50 Years of Cannabis Research
Congressional Briefing: The Path Forward for a Safe Cannabis Marketplace
Update: Disturbing Increase in Children Confusing Marijuana Edibles for Candy
Cannabis Consumer Watch Responds to Bipartisan RFI Regarding FDA-Regulation of CBD
ICYMI: Disparities Between Cannabis Product Health Claims and Research: Magnified Risks for Women
Code 3 Urges Consumers to Beware of Unregulated Cannabis Products
ICYMI: Cannabis-related ER Visits Spiked During the Pandemic
Delta-8: Added Confusion and Risks in the Cannabis Marketplace
Test your Cannabis Knowledge
NCL statement on FDA review of the oral toxicity of cannabidiol (CBD)
ICYMI: NCL’s Strongin Highlights Need for FDA Oversight of Medical Marijuana Misinformation Online
Mental Health Awareness Month: What You Should Know About Cannabis and Your Mental Health
ICYMI: New York Times Highlights Concerns Related to Cannabis Use Disorder
New White Paper Analyzes Marijuana Companies Health Claims on Social Media
NCL Responds to the FDA's decision regarding CBD regulatory framework
ICYMI: NCL welcomes FDA heightened concerns related to CBD products
“Buyer Beware” During This Holiday Season
NCL, CADCA Express Concerns About MLB Partnership with Cannabis Company
Cannabis-Derived Goodies: More Tricks than Treats
Recent Studies Have Put Cannabis and Mental Health Risks in the Spotlight
More People Are Smoking Cannabis Than Cigarettes, But It May Be No Better for Your Health
After local students sickened, here's what parents should know about cannabis-infused products
Expanded Efforts to Ensure a Safe Cannabis Marketplace
Legislation To Reaffirm FDA’s Role in Ensuring Safe Marketplace for Cannabis & CBD
New Minnesota Law Reiterates the Need for Federal Regulation of Cannabis
ICYMI: Weed users nearly 25% more likely to need emergency care and hospitalization
ICYMI: Lots of 'THC-Free' CBD Products Contain THC: Study
Cannabis Products Aren’t What They Seem
ICYMI: Medical Cannabis Reimbursement Debate in the Courts Highlights Need for FDA Clarity
Copycat Marketing Puts Consumers At Risk
Doctors Know Best When it Comes to Addressing Mental Health
ROI New Jersey: Cannabis can’t cure COVID — and other misleading claims
Cannabis Claims: New Website Analyzes Medical Marijuana Companies’ Misleading Marketing Practices
Medical Claims and Cannabis: Read the Fine Print
Cannabis Companies Exploit Academic Partnerships for Marketing
PA Spotlight Investigation: Unproven, Unsafe
Research for Medicines vs. Research for Marketing
ICYMI: It’s too early to tell whether CBD helps against Covid-19...
National Consumers League Highlights New Research on CBD Companies Marketing Tactics
Be Merry – and Safe – this Holiday Season
More Concerns about Synthetically Manufactured Cannabinoid Products
NCL Applauds Califf Nomination, Encourages FDA to Focus on CBD
National Health Education Week: CBD Is Not Necessarily Healthy
Morning Consult Opinion: The FDA Can Help Keep Consumers Safe When It Comes to CBD
FDA & CDC Warns Consumers About Serious Health Risks Associated with Delta-8 THC
The Hidden Dangers of CBD: It’s Just Not Worth the Risk
Regulating Cannabis and CBD: Congress and the Administration Weigh In
